ONCOSEC MEDICAL INCORPORATED
CIK 0001444307
Revenue (TTM)
$0
Q2 Mar 2023
Net Income (TTM)
−$31.08M
+24.3% YoY
Q2 Mar 2023
EPS Diluted (TTM)
−$1.65
+33.3% YoY
Q2 Mar 2023
Gross Margin
—
Q2 Mar 2023
Operating Margin
—
Q2 Mar 2023
Net Margin
—
Q2 Mar 2023
Free Cash Flow (TTM)
−$34.8M
Q2 Mar 2023
Cash
$3.68M
Q2 Mar 2023
Total Debt
$936.56K
Q2 Mar 2023
Shares Outstanding
2.97M sh
Q2 Mar 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.